<h1>Healthcare chain names new CEO, plans expansion to 100 clinics and ?100 crore turnover by FY 2025-26; governance implications</h1> A healthcare chain appointed a new CEO and announced plans to expand from 11 to 100 clinics and target a ?100 crore turnover by FY 2025-26, citing prior experience scaling and listing another healthcare business. Founders remain the clinic's originators. The announcement has corporate governance and regulatory implications: board approvals, disclosure and securities rules if fundraising or listing follows, state licensing and medical regulatory compliance for multisite operations, advertising and treatment claims scrutiny, patient data/privacy obligations, and employment and commercial contracting across jurisdictions. Potential risks include regulatory enforcement, professional liability, and obligations under consumer protection and healthcare laws.